Piers Gaunt

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +5

Early phase clinical trials extension to guidelines for the content of statistical analysis plans

Victoria Homer, Christina Yap, Simon Bond et al. · BMJ · 2022 · 64 citations · Full text

Pharmacy, Biostatistics, Clinical Data Management +13

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial

Matthew J. Armstrong, Darren Barton, Piers Gaunt et al. · BMJ Open · 2013 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial

Penella J. Woll, Piers Gaunt, Sarah Danson et al. · Lung Cancer · 2022 · 42 citations · Full text

Medicine, Oncology, Pharmacology +12

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial

Ava Lorenc, Mary Wells, Tessa Fulton‐Lieuw et al. · Clinical Oncology · 2021 · 38 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +7